Of the experiments showing a beneficial effect of IL11 in liver disease, the 2001 study by Trepicchio that showed a protective effect of rhIl11 in APAP-induced murine liver failure caught our attention, as effects were acute, dose-dependent and we replicated the findings [37,61]. The gene discussed is IL11; the disease is liver disorder.